A detailed history of N Verses Capital, LLC transactions in Regenxbio Inc. stock. As of the latest transaction made, N Verses Capital, LLC holds 3,400 shares of RGNX stock, worth $32,572. This represents 0.02% of its overall portfolio holdings.

Number of Shares
3,400
Previous 1,200 183.33%
Holding current value
$32,572
Previous $14 Million 154.03%
% of portfolio
0.02%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

BUY
$10.49 - $14.39 $23,078 - $31,658
2,200 Added 183.33%
3,400 $35.7 Million
Q2 2024

Jul 31, 2024

BUY
$11.51 - $21.53 $13,812 - $25,836
1,200 New
1,200 $14 Million

Others Institutions Holding RGNX

About REGENXBIO Inc.


  • Ticker RGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,230,000
  • Market Cap $414M
  • Description
  • REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...
More about RGNX
Track This Portfolio

Track N Verses Capital, LLC Portfolio

Follow N Verses Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of N Verses Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on N Verses Capital, LLC with notifications on news.